PD-L1 Promotes Tumor Progression, Chemotherapy Resistance, and Poor Clinical Outcomes in Non-Small C

来源 :第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 | 被引量 : 0次 | 上传用户：B08050402

【摘要】

：

　　Objective: Although neoadjuvant chemotherapy (NAC) for advanced lung cancer can improve operability and local disease control, the duration of benefit is li

【作者】

：

Zhang Panpan Yuanyuan Ma

【机构】

：

Peking University Cancer Hospital & Institute, Beijing , China

【出处】

：

第十八届全国临床肿瘤学大会暨2015年CSCO学术年会

【发表日期】

：

2015年期

下载到本地 , 更方便阅读

下载此文赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

　　Objective: Although neoadjuvant chemotherapy (NAC) for advanced lung cancer can improve operability and local disease control, the duration of benefit is limited before resistance develops.

其他文献

A single center, single arm and Phase Ⅱ clinical trail: the study of efficacy and safety of pulsatil

　　Objective: To observe the efficacy and safety of pulsatile administration of high-dose gefitinib or erlotinib for advanced non-small cell lung cancer patien

会议

Prognostic significance of survivin and thyroid transcription factor-1 in small cell lung cancer

　　Objective: Small cell lung cancer (SCLC) is a refractory subtype of lung cancer characterized by limited drug responses, aggressive metastasis and relapse a

会议

Effect and mechanism of elemene in radiosensitivity in A549 lung adenocarcinoma cells

　　Objective: To investigate the effect of elemene on the radiosensitivity of A549 cells and its possible molecular mechanism.Method: The effect on cell radios

会议

Activity of the c-Met inhibitor tepotinib (MSC2156119J) in combination with gefitinib in Asian patie

　　Objective: c-Met abnormalities can cause resistance to EGFR TKIs in EGFR mutant NSCLC patients (pts).The highly selective c-Met inhibitor tepotinib (MSC2156

会议

The Status of Single Lung Lesion in Patients with History of Previous Malignancy: a Cross-sectional

　　Objective: Defining the status of single lung lesion and making treatment strategy was intricate, and had been well studied for decades.However, seldom stud

会议

IMRT Improves Survival in Locally Advanced NSCLC (LA-NSCLC) Receiving Definitive Radiotherapy:A Popu

　　Objective: Currently intensity-modulated radiotherapy (IMRT) is regarded as a promising but unproven therapy for locally advanced non-small cell lung cancer

会议

Inhibiting autophagy promotes cisplatin-induced apoptotic cell death in A549 human lung cancer cells

　　Objective: Recent studies indicate that autophagy is adouble-edged sword in tumor genesis and plays an important role in theresistance of cancer cells to ch

会议

Retrospective analysis of efficacy of gefitinib in non small cell lung cancer

　　Objective: The primary end points of this study are: 1.Overall Survival in patients of NSCLC on gefitinib.The secondary end points of this study are: 2.Prog

会议

DNA repair protein APE 1 is a novel biomarker to predict platinum resistance in non-small cell lung

　　Objective: As one of the major cancers with a high mortality rate, lung cancer is still a huge health challenge worldwide.Although platinum-based doublet ch

会议

Determining the prevalence of EGFR mutations in patients with advanced non-small-cell lung cancer (a

　　Objective: IGNITE (a large, multinational, diagnostic, non-comparative, interventional study;NCT01788163) assessed EGFR mutation frequency in patients with

会议

PD-L1 Promotes Tumor Progression, Chemotherapy Resistance, and Poor Clinical Outcomes in Non-Small C

其他学术论文